Tevogen Bio Announces Partnership With BioCentriq, New Jersey Innovation Institute’s Pioneering Cell and Gene Therapy Center, to Enhance Tevogen’s Development Capacity of Its Proprietary Targeted T Cell Therapy For COVID-19

https://www.businesswire.com/news/home/20210315005509/en/Tevogen-Bio-Announces-Partnership-With-BioCentriq-New-Jersey-Innovation-Institute%E2%80%99s-Pioneering-Cell-and-Gene-Therapy-Center-to-Enhance-Tevogen%E2%80%99s-Development-Capacity-of-Its-Proprietary-Targeted-T-Cell-Therapy-For-COVID-19